Lactams Exhibit Potent Antifungal Activity Against Monospecies and Multispecies Interkingdom Biofilms on a Novel Hydrogel Skin Model
APMIS · 2025
DOI: 10.1111/apm.13510 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Hafsa Abduljalil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oral Sciences Research Group, Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, Gla…. Hauptthemen laut MEDLINE: Biofilms, Antifungal Agents, Lactams, Microbial Sensitivity Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Biofilms Innovation Centre.
Abstract (Originalsprache)
Infections of intact and damaged skin barriers and keratin are frequently associated with complex biofilm communities containing bacteria and fungi, yet there are limited options for successful management. This study intended to focus on the utility of some novel proprietary lactam molecules, quorum sensing (QS)–derived halogenated furanones, which act to block the QS pathway, against key fungal pathogens of the skin ( Candida albicans , Malassezia furfur and Microsporum gypseum ). Moreover, we aimed to assess how these actives performed against complex interkingdom biofilms in a clinically relevant model. Two lactam derivatives were tested against a panel of important fungal pathogens and then quantitatively assessed against simple and increasingly complex interkingdom biofilm models on polystyrene coverslips and a novel keratin hydrogel system. The lactams were shown to be effective against a wide range of fungal species in the planktonic and biofilm forms, with no ability to regrow. The fungal component of the multispecies biofilm models was significantly reduced with lactam treatment. Lactam treatment was also comparably effective compared to the non‐prescription topical antifungal ‘Lamisil’ against C. albicans early and late biofilms. This study highlights the effectiveness of lactams as a novel antimicrobial for the management of the polymicrobial and interkingdom multispecies biofilms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oral Sciences Research Group, Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, Glasgow, UK.
- Safeguarding Health Through Infection Prevention (SHIP) Research Group, Research Centre for Health, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
- Unilever R&D, Bebington, Wirral, UK.
- Penrhos Bio Limited, London, UK.
ORCID-Profile: Gordon Ramage
Förderung
- National Biofilms Innovation Centre
Zitieren
APA
Abduljalil, H., Alshanta, O. A., Chougule, S., Butcher, M., Short, B., McLean, W., Parry, N., O'Keeffe, J., & Ramage, G. (2025). Lactams Exhibit Potent Antifungal Activity Against Monospecies and Multispecies Interkingdom Biofilms on a Novel Hydrogel Skin Model. APMIS. https://doi.org/10.1111/apm.13510
Vancouver
Abduljalil H, Alshanta OA, Chougule S, Butcher M, Short B, McLean W, et al. Lactams Exhibit Potent Antifungal Activity Against Monospecies and Multispecies Interkingdom Biofilms on a Novel Hydrogel Skin Model. APMIS. 2025. doi:10.1111/apm.13510
BibTeX
@article{Abduljalil2025,
author = {Abduljalil, Hafsa and Alshanta, Om Alkhir and Chougule, Safa and Butcher, Mark and Short, Bryn and McLean, William and Parry, Neil and O'Keeffe, Joanne and Ramage, Gordon},
title = {Lactams Exhibit Potent Antifungal Activity Against Monospecies and Multispecies Interkingdom Biofilms on a Novel Hydrogel Skin Model},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.13510}
}
EUVIMED